VERRICA PHARMACEUTICALS INC (VRCA)
US92511W1080 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -84.99M | -67.00M | -24.49M | -35.08M | -42.69M | |||
| Depreciation Amortization | 920.00K | 550.00K | 450.00K | 240.00K | 40.00K | |||
| Change In Working Capital | 10.99M | 9.86M | -1.80M | -540.00K | 1.64M | |||
| Interest Paid | 7.32M | 3.15M | 1.79M | 2.85M | 1.88M | |||
| Other non cash items | 13.71M | 18.01M | 7.18M | 7.79M | 10.81M | |||
| OPERATING CASH FLOW | -59.37M | -38.58M | -18.65M | -27.58M | -30.21M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -249.00K | -362.00K | -300.00K | -880.00K | -1.47M | |||
| Other Investing Activity | N/A | 0.00 | 54.34M | -120.00K | -2.11M | |||
| INVESTING CASH FLOW | -249.00K | -362.00K | 54.04M | -1.00M | -3.58M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.72M | 44.08M | -43.75M | 4.97M | 34.46M | |||
| Stock Issued/Repurchased | 151.00K | 30.31M | 26.90M | 28.68M | 450.00K | |||
| Other Financing Activity | -169.00K | -176.00K | -20.00K | 0.00 | 320.00K | |||
| FINANCING CASH FLOW | -1.73M | 74.21M | -16.87M | 33.65M | 35.23M | |||
| CHANGE IN CASH | -61.34M | 35.27M | 18.52M | 5.07M | 1.44M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -59.37M | -38.58M | -18.65M | -27.58M | -30.21M | |||
| Capital Expenditure | -249.00K | -362.00K | -300.00K | -880.00K | -1.47M | |||
| FREE CASH FLOW | -59.62M | -38.94M | -18.95M | -28.46M | -31.68M | |||
All data in USD